264 related articles for article (PubMed ID: 31507152)
1. Clinical practice update of antifungal prophylaxis in immunocompromised children.
Ramos JT; Romero CA; Belda S; Candel FJ; Carazo Gallego B; Fernández-Polo A; Ferreras Antolín L; Garrido Colino C; Navarro ML; Nef O; Olbright P; Rincón-López E; Ruiz Contreras J; Soler-Palacín P;
Rev Esp Quimioter; 2019 Oct; 32(5):410-425. PubMed ID: 31507152
[TBL] [Abstract][Full Text] [Related]
2. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Solano C; Slavin M; Shaul AJ; Marks DI; Cordonnier C; Cornely OA; Pagliuca A; Cragin L; Jarque I; Garcia-Vidal C; Sorensen S; Vanness DJ; Charbonneau C; Barrueta JA; Peral C; De Salas-Cansado M; Bow EJ
Mycoses; 2017 Feb; 60(2):79-88. PubMed ID: 27562016
[TBL] [Abstract][Full Text] [Related]
5. Clinical considerations in the early treatment of invasive mould infections and disease.
Mercier T; Maertens J
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i29-i38. PubMed ID: 28355465
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients.
Lehrnbecher T; Fisher BT; Phillips B; Beauchemin M; Carlesse F; Castagnola E; Duong N; Dupuis LL; Fioravantti V; Groll AH; Haeusler GM; Roilides E; Science M; Steinbach WJ; Tissing W; Warris A; Patel P; Robinson PD; Sung L
J Clin Oncol; 2020 Sep; 38(27):3205-3216. PubMed ID: 32459599
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
8. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
9. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
10. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.
Leonart LP; Tonin FS; Ferreira VL; Penteado STS; Wiens A; Motta FA; Pontarolo R
J Clin Pharm Ther; 2017 Oct; 42(5):530-538. PubMed ID: 28620958
[TBL] [Abstract][Full Text] [Related]
11. Invasive fungal infections: managing the continuum of risk in HCT patients.
Duarte RF; Lyon S
Future Microbiol; 2017 Aug; 12():843-846. PubMed ID: 28685597
[TBL] [Abstract][Full Text] [Related]
12. Antifungal prophylaxis in immunocompromised hosts.
Reents S; Goodwin SD; Singh V
Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
[TBL] [Abstract][Full Text] [Related]
14. Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.
Chan SY; Hughes RM; Woo K; Perales MA; Neofytos D; Papanicolaou G
Med Mycol; 2020 Nov; 58(8):1029-1036. PubMed ID: 32171012
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.
Douglas AP; Slavin MA
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
[TBL] [Abstract][Full Text] [Related]
17. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
18. [Fungal infection in immunocompromised children].
González-Vicent M; Ramos-Amador JT
Rev Iberoam Micol; 2021; 38(2):75-83. PubMed ID: 34148786
[TBL] [Abstract][Full Text] [Related]
19. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA; Girmenia C; Brüggemann RJ; Duarte RF; Kibbler CC; Ljungman P; Racil Z; Ribaud P; Slavin MA; Cornely OA; Peter Donnelly J; Cordonnier C; ;
J Antimicrob Chemother; 2018 Dec; 73(12):3221-3230. PubMed ID: 30085172
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Invasive Fungal Disease in Children.
Pana ZD; Roilides E; Warris A; Groll AH; Zaoutis T
J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S3-S11. PubMed ID: 28927200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
